13.5.3 Drugs affecting the immune response
Abrocitinib
Adalimumab
Amgevita 20mg/0.2ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Amgevita 20mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Amgevita 40mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Amgevita 40mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Amgevita 40mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Amgevita 40mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Amgevita 80mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Skin | Hidradenitis suppurativa |
Amgevita 80mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Skin | Hidradenitis suppurativa |
Apremilast
Otezla 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Otezla 20mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Otezla 30mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Azathioprine
Azathioprine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Autoimmune bullous dermatoses |
| Skin | Eczema |
Azathioprine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Autoimmune bullous dermatoses |
| Skin | Eczema |
Baricitinib
Bexarotene
Targretin 75mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Cutaneous T-cell lymphoma |
Bimekizumab
Bimzelx 160mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Bimzelx 160mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Bimzelx 320mg/2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Bimzelx 320mg/2ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Brodalumab
Kyntheum 210mg/1.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Certolizumab pegol
Chlormethine
Ledaga 160micrograms/g gel
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Cutaneous T-cell lymphoma |
Ciclosporin
Capimune 100mg capsules
Capimune 25mg capsules
Capimune 50mg capsules
Neoral 100mg/ml oral solution
Deucravacitinib
Sotyktu 6mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Dimethyl fumarate
Dupilumab
Etanercept
Benepali 25mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Benepali 50mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Benepali 50mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Guselkumab
Tremfya 100mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Infliximab
Remsima 100mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Skin | Psoriasis |
Remsima 120mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Skin | Psoriasis |
Ixekizumab
Taltz 80mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Taltz 80mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Lebrikizumab
Methotrexate
Methotrexate 10mg/5ml oral solution
Methotrexate 2.5mg tablets
Metoject PEN 10mg/0.2ml solution for injection pre-filled pens
Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens
Metoject PEN 15mg/0.3ml solution for injection pre-filled pens
Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens
Metoject PEN 20mg/0.4ml solution for injection pre-filled pens
Metoject PEN 22.5mg/0.45ml solution for injection pre-filled pens
Metoject PEN 25mg/0.5ml solution for injection pre-filled pens
Mycophenolate mofetil
Mycophenolate mofetil 250mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Autoimmune bullous dermatoses |
| Skin | Eczema |
Mycophenolate mofetil 500mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Autoimmune bullous dermatoses |
| Skin | Eczema |
Omalizumab
Pimecrolimus
Pimecrolimus 1% cream
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Eczema |
Risankizumab
Skyrizi 150mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Skyrizi 150mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Skyrizi 75mg/0.83ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Secukinumab
Cosentyx 150mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Cosentyx 150mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Cosentyx 300mg/2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Hidradenitis suppurativa |
| Skin | Psoriasis |
Tacrolimus
Tildrakizumab
Ilumetri 100mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Psoriasis |
Tralokinumab
Adtralza 150mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Skin | Eczema |
Upadacitinib
Rinvoq 15mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Eczema |
Rinvoq 30mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Skin | Eczema |
Ustekinumab
Pyzchiva 45mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Pyzchiva 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Wezenla 45mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Wezenla 45mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Wezenla 45mg/0.5ml solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Wezenla 90mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |
Wezenla 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Skin | Psoriasis |